Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Latest filing published 03 Mar 2023 for Opiant Pharmaceuticals, INC., €184k. Read the official filing
Filing timeline
BuySalePhil Skolnick
Insider track record
Disclosed buys
0
Disclosed sells
6
Signal history
Phil Skolnick: trading record in brief
Phil Skolnick (senior executive) discloses dealings in Opiant Pharmaceuticals, Inc. to SEC (Form 4). We count 9 filings; the first trade dates from 4 January 2022 and the latest from 2 March 2023.
The open-market record consists of 6 sales worth €96k, with no purchase. Besides market trades, the filings include 2 share grants. 2023 to date brings no purchases and 3 sales.
The newest entry dates from 3 March 2023: a transaction of €184k, in Opiant Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Phil Skolnick
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
9,812 shares@ US$20.0065.7% of flowCommon StockSEC:0001385508-23-000065:0
480 shares@ US$20.263.2% of flowCommon StockSEC:0001385508-23-000031:0
369 shares@ US$20.202.5% of flowCommon StockSEC:0001385508-23-000020:0
1,421 shares@ US$20.209.7% of flowCommon StockSEC:0001385508-23-000007:0
627 shares@ US$11.852.6% of flowCommon StockSEC:0001385508-22-000111:0
2,000 shares0Common StockSEC:0001385508-22-000101:0
1,518 shares@ US$26.1912.6% of flowCommon StockSEC:0001385508-22-000026:0
385 shares@ US$30.493.7% of flowCommon StockSEC:0001385508-22-000021:0
12,000 shares0Common StockSEC:0001385508-22-000013:0
9 of 9 declarations
